Kristen N Ganjoo Selected Research

Kristen N Ganjoo Research Topics

Disease

22	Sarcoma (Soft Tissue Sarcoma) 11/2022 - 11/2009
19	Neoplasms (Cancer) 11/2022 - 01/2002
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2020 - 11/2009
5	Leiomyosarcoma 01/2020 - 06/2009
4	Aggressive Fibromatosis (Desmoid) 01/2022 - 08/2012
4	Hypoxia (Hypoxemia) 01/2017 - 07/2010
3	Disease Progression 01/2022 - 06/2014
3	Nausea 01/2022 - 01/2015
3	Fatigue 01/2022 - 03/2012
3	Neutropenia 01/2017 - 01/2002
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015 - 03/2012
3	Lymphoma (Lymphomas) 06/2014 - 04/2005
2	Liposarcoma 01/2022 - 11/2020
2	Vomiting 01/2022 - 01/2015
2	Hemangiosarcoma (Angiosarcoma) 01/2022 - 01/2018
2	Ewing Sarcoma (Sarcoma, Ewing) 09/2020 - 12/2011
2	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 06/2006
1	Rare Diseases (Rare Disease) 03/2022
1	Neurilemmoma (Schwannoma) 03/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Anemia 01/2022
1	Myxoid Liposarcoma 01/2022
1	Synovial Sarcoma (Synovioma) 01/2022
1	Diarrhea 01/2022
1	Epistaxis (Nosebleed) 01/2022
1	Headache (Headaches) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Necrosis 12/2021
1	Dermatitis 01/2021
1	Genetic Translocation (Chromosomal Translocation) 09/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Cardiotoxicity 10/2018
1	Anaplastic Thyroid Carcinoma 04/2018
1	Solitary Fibrous Tumors 01/2017
1	Febrile Neutropenia 01/2017
1	Lactic Acidosis 01/2017
1	Heart Failure 01/2017
1	Death (Near-Death Experience) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Stomatitis 01/2017
1	Sepsis (Septicemia) 01/2017
1	Chordoma 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Chondrosarcoma 01/2017

Drug/Important Bio-Agent (IBA)

6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 01/2011
6	Pharmaceutical PreparationsIBA 10/2018 - 11/2009
5	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 11/2009
4	ProdrugsIBA 01/2017 - 07/2010
3	regorafenibIBA 11/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2009
3	Sunitinib (Sutent)FDA Link 01/2018 - 04/2010
3	Dasatinib (BMS 354825)FDA Link 01/2018 - 03/2016
3	Rituximab (Mabthera)FDA Link 01/2017 - 06/2006
3	TH 302IBA 01/2017 - 01/2011
3	Monoclonal AntibodiesIBA 01/2015 - 07/2010
3	Gemcitabine FDA Link 04/2005 - 01/2002
2	pazopanib FDA Link 01/2022 - 11/2020
2	AnthracyclinesIBA 01/2022 - 10/2018
2	Biological ProductsIBA 12/2021 - 06/2015
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 06/2014
2	Bevacizumab (Avastin)FDA Link 01/2018 - 06/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 12/2007
2	ocaratuzumabIBA 01/2015 - 03/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 07/2010
2	LigandsIBA 07/2010 - 12/2007
2	Tyrosine Kinase InhibitorsIBA 07/2010 - 04/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008 - 06/2006
2	Docetaxel (Taxotere)FDA Link 01/2003 - 01/2002
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Yttrium-90IBA 01/2022
1	selinexorIBA 01/2022
1	carotuximabIBA 01/2022
1	nirogacestatIBA 01/2022
1	beta CateninIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	atezolizumabIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Methotrexate (Mexate)FDA LinkGeneric 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 11/2020
1	olaratumabIBA 01/2020
1	DOXO-EMCHIBA 10/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2018
1	Circulating Tumor DNAIBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	IronIBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	SulfurIBA 01/2018
1	isophosphamide mustard (IPAM)IBA 01/2017
1	Bendamustine Hydrochloride FDA Link 01/2017

Therapy/Procedure

16	Therapeutics 11/2022 - 04/2009
5	Radiotherapy 11/2022 - 04/2014
4	Drug Therapy (Chemotherapy) 01/2022 - 06/2014
2	Neoadjuvant Therapy 12/2021 - 12/2021
1	Adjuvant Radiotherapy 03/2022
1	Continuity of Patient Care 01/2017